October 2002

Practical Medicine:

January 14, 2010

Diagnosing the condition DERMAN. Insurance and reimbursement are two big challenges. Part of the problem is that reimbursement rates have dropped, thus physicians need to see more patients, more efficiently, in the same period of time to cover overhead. This is true even in an academic environment. The days of external support for the clinicalpractice […]

Dr. Jon Adler — Medicine Man

January 14, 2010

Man FROM THE EMERGENCY ROOM TO THE BOARDROOM, Jonathan N. Adler, M.D., is committed to the practice of medicine. As a physician, lecturer, and president and chief medical officer of eMedicine, he balances all endeavors with one goal in mind: fostering better medicine. BY KIM RIBBINK JON Adler PharmaVOICE The demands of medicine mean physicians […]

Xyrem: Awakenings

January 14, 2010

PharmaVOICE approved for treating cataplexy. Of the esti mated 140,000 Americans who suffer from narcolepsy, between 60% and 90% experience cataplexy. Orphan Medical Inc. developed Xyrem under the FDA’s Orphan Drug Act of 1983, which provides market exclusivity to companies that develop products for small, underserved patient populations. While the Orphan Drug Act provides some […]

Brand-cycle management

January 14, 2010

By 2005, many multibillion dollar drugs will come off patent, including blockbuster drugs such as Claritin, Viagra, Glucophage, and Prilosec (see chart on page 51). The finan cial incentives for prolonging the life of these brands are enormous. Last year, Claritin earned almost $2 billion in sales. Viagra earned almost the same amount. In the […]

PDUFA III

January 14, 2010

As time was about to expire, Congress approved legislation reauthorizing the Prescription Drug User Fee Act of 1992 (PDUFA) for five years. The reauthorization of PDUFA was included in the bioterrorism leg islation passed in May by both houses of Congress, and was signed into law by President Bush on June 11th. Without approval, PDUFA […]

Thought-Full Relationships

January 14, 2010

In the drive for market success, top companies are harnessing and capitalizing on knowledge “owned” by specialists, often referred to as thought leaders. According to Best Practices Inc., Pfizer successfully employed thoughtleader endorsements by consulting the Vatican when releasing Viagra and letting physicians review directtocon sumer advertising before launching the campaign. Thoughtleader relationship management is […]

Pushing Past the Paper

January 14, 2010

PharmaVOICE W While adoption of a paperless approach by pharmaceutical companies has been gradual, Forrester Research, based on a recent survey of 400 pharmaceutical profession als, is projecting that 24% of all new clinical trials will be Web enabled by 2004. Integrated electronic applica tion, many say, is the next step in the evolutionary process. […]

Talent Pool

January 13, 2010

Pharma POOL Dr. Jack GOLDSTEIN Chiron Names Blood Testing Division President Chiron Corp. has named Jack Goldstein, Ph.D., president of Chi ron’s blood testing division. Dr. Goldstein is responsible for the commercial operations of Chiron’s blood testing business, based in Emeryville, Calif. He also serves as a member of Chiron’s executive committee. William G. Green, […]

E-Media

January 13, 2010

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES The Rosetta Luminator system, a clientserver bioinformatics system for storing and analyzing microarray data, has been launched by Rosetta Biosoftware and Agilent Technologies Inc. The geneexpression data analysis solution was developed to meet the needs of small to medi umsize pharmaceutical and biotechnology corporations, as well as […]

What’s New

January 13, 2010

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES TrialCard’s patented “IA Technology” is designed to replace prepackaged drug samples. By using a device similar to a credit card that can be activated and deactivated, manufacturers can distribute their samples through pharmacies, and can implement patient assistance programs, clinical trials, and cus tomer loyalty and reward programs. The […]

PharmaTrax

January 13, 2010

NEUROTHERAPEUTICS AND GENE AMPLIFICATION Markets Predicted to Grow Unmet need and ballooning incidence are expected to create huge market potential in neuro logical drugs,according to a study by Kalorama Infor mation. The world market stands at $70 billion, but steady growth in demand and product introduction will result in markets in excess of $88 billion […]

For Art’s Sake

January 13, 2010

CREATIVE review There are many times in healthcare advertising when humor is not appropriate,but for every ad that misuses humor there are hundreds of others that have wasted the opportunity to elicit a chuckle or to add a touch of irony. Humor is one of the most underutilized tools that we have. Humor is a […]

Pharma Outlet

January 13, 2010

Fewer new drug approvals, the political spotlight on the pharmaceutical industry, promotional budget cutbacks. What else can go wrong in the healthcare communications industry? Pitted against their more endowed competitors, small agencies may be wellsuited to survive in today’s adverse environment. They don’t carry huge overhead, are managed by seasoned managers, and are unencumbered by […]

What’s on your mind: Opinions

January 13, 2010

R&D will tell I am not sure that the mega company strategy/structure will support the trend toward biopharmaceutical products (and fur ther into the future, gene therapies) that offer therapeutic solutions for more specific diseases. The trend toward blockbuster product launches will give way to more targeted medicines, diagnostics, and devices. Advancements in medicine that […]

Raise Your Voice: Letters

January 13, 2010

Missed opportunity I applaud the fact that PharmaVOICE has highlighted the importance of the new PhRMA Voluntary Marketing Code, but I would be remiss if I didn’t ask: “Where in this article is the discussion about the benefit of the new code to the patient?” In reading through this 11 page article, the word “patient” […]

Letter from the Editor

January 13, 2010

PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Virginia Kirk Denise Myshko Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Number Seven PharmaVOICE is published eight times per year by PharmaLinx LLC, P.O. […]

FEEDBACK